MedTrace Logo

Safety Assessment of Angioplasty Procedures

NCT03893396 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 983

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

Ischemic heart disease, or coronary heart disease, covers a set of pathologies due to insufficient oxygen supply to the myocardium due to the development of atherosclerosis in one or more coronary arteries. To evaluate the safety of angioplasty performed in patients operated on at La Rochelle Hospital, the rate of major adverse cardiac events (MACE) will be determined and compared with data from the literature.

Conditions

  • Angiospastic; Disorder

Interventions

DEVICE

Coronary angioplasty

Procedure used to open clogged heart arteries. Involves the insertion of a tiny balloon and/or a stent to widen the artery.

Sponsors & Collaborators

  • BBraun Medical SAS

    collaborator INDUSTRY

  • Groupe Hospitalier de la Rochelle Ré Aunis

    lead OTHER

Principal Investigators

  • Ludovic MEUNIER, MD · Groupe Hospitalier de la Rochelle Ré Aunis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2021-03-30
Completion
2023-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03893396 on ClinicalTrials.gov